核糖体S6激酶2的不对称二甲基化调节其细胞局部和亲存活功能
Mahmoud I Khalil1,2, Heba M Ismail3,4, Ganna Panasyuk5,6
1Molecular Biology Unit, Department of Zoology, Faculty of Science, Alexandria University, Alexandria 21568, Egypt.
International journal of molecular sciences
|May 27, 2023
概括
蛋白质氨酸甲基化修改了Ribosomal S6激酶2 (S6K2),在饥饿期间促进其核局部化和亲生存功能. 这种甲基化对于S6K2在癌症进展中的活性至关重要.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 后翻译修改后的修改.
背景情况:
- 核糖体S6激酶 (S6Ks) 调节细胞生长和存活,与癌症相关的失调.
- 虽然S6K1已被广泛研究,但S6K2在癌症进展中的作用仍未得到充分研究.
- 蛋白质氨酸甲基化是细胞过程中关键的翻译后修饰.
研究的目的:
- 为了研究S6K2.2.的翻译后修改.
- 阐明氨酸甲基化在S6K2功能和局部化中的作用.
- 探索S6K2甲基化在癌症生物学中的影响.
主要方法:
- 在体外和体外与蛋白质氨酸甲基转移酶 (PRMT) 的相关性研究.
- 在特定的氨酸残留物 (Arg-475和Arg-477) 中对S6K2甲基化的分析.
- 细胞局部化研究和在饥饿条件下对生存效应的评估.
主要成果:
- 在Arg-475和Arg-477,p54-S6K2经历了不对称的二甲基化.
- S6K2与PRMT1,PRMT3和PRMT6结合,调解这种甲基化.
- 甲基化驱动S6K2的核定位,这对于其在饥饿诱导的细胞死亡期间的生存作用至关重要.
结论:
- 氨酸甲基化是对p54-S6K2功能的新型调节机制.
- 这种修改影响了S6K2的细胞定位和生存信号.
- S6K2甲基化可能是癌症进展的重要因素,特别是当阿金甲基化升高时.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Translational Regulation
46
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
46


